Invivyd Inc

The stock IVVD is in a Stage 4 decline with a confirmed series of lower highs and lower lows below declining EMAs, supported by distribution volume dominance. Medium-term directional bias is bearish, and near-term pullbacks into the 9/21 EMAs create favorable sell-side entry opportunities. While RSI shows extreme oversold readings, the lack of mean-reversion eligibility and failure of rallies at EMAs suggest downward momentum remains intact. We recommend immediate bearish engagement at resistance zones around the 9/21 EMAs.

• ↑22% YoY Pemgarda revenue growth to $12.5M signals robust demand
• ↑$80M cash runway supports VYD2311 trials and commercialization
• ↓FDA EUA for Pemgarda under heightened regulatory scrutiny